Cost-related medication nonadherence among elderly and disabled medicare beneficiaries - A national survey 1 year before the medicare drug benefit

被引:197
|
作者
Soumerai, Stephen B.
Pierre-Jacques, Marsha
Zhang, Fang
Ross-Degnan, Dennis
Adams, Alyce S.
Gurwitz, Jerry
Adler, Gerald
Safran, Dana Gelb
机构
[1] Harvard Univ, Med Sch & Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
[3] Meyers Primary Care Inst, Worcester, MA USA
[4] US Dept HHS, Ctr Medicare, Baltimore, MD USA
[5] US Dept HHS, Ctr Medicaid, Baltimore, MD USA
[6] Tufts Univ, Sch Med, Boston, MA 02111 USA
[7] Tufts Univ New England Med Ctr, Hlth Inst, Boston, MA USA
关键词
D O I
10.1001/archinte.166.17.1829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prior to implementation of the Medicare drug benefit, we estimated the prevalence of cost-related medication nonadherence (CRN) among Medicare enrollees, including elderly and nonelderly disabled beneficiaries. Methods: In the fall of 2004, detailed measures of CRN (skipping or reducing doses or not filling prescriptions because of cost) were added to the Medicare Current Beneficiary Survey. We examined the prevalence of CRN nationally and by Medicare eligibility subgroups (elderly vs nonelderly disabled beneficiaries), drug coverage status, socioeconomic status, self-rated health, and number of chronic medical conditions. Results: In a national sample of 13 835 noninstitutionalized Medicare enrollees, 29% of the disabled and 13% of the elderly beneficiaries reported CRN; those in fair to poor health with multiple comorbidities and without coverage were most at risk. Among the disabled enrollees with 4 or more morbidities, 52% (95% confidence interval [CI], 43.3%-60.3%) without drug coverage skipped prescriptions or doses compared with 26% (95% CI, 17.7%-34.8%) with Medicaid drug coverage. Those with partial drug coverage through Medigap policies or Medicare health maintenance organizations reported intermediate rates of CRN. The adjusted odds ratio of CRN among disabled enrollees in poor (vs good) health was 3.9 (95% CI, 1.7-9.2), whereas for those with 4 or more (vs < 4) comorbidities, the odds ratio of CRN was 2.7 (95% CI, 1.7-4.1). Conclusions: One year before Medicare Part D implementation, Medicare beneficiaries reported high rates of CRN. Rates are highest among nonelderly disabled beneficiaries, but among both elderly and disabled beneficiaries, CRN is exacerbated by poor health, multiple morbidities, and limited drug coverage. Given the high cost sharing under Part D, it is important to closely monitor CRN in high-risk subgroups.
引用
收藏
页码:1829 / 1835
页数:7
相关论文
共 50 条
  • [31] Declines in cost-related medication nonadherence and in forgoing basic needs following Medicare Part D
    Madden, J. M.
    Graves, A. J.
    Zhang, F.
    Adams, A. S.
    Briesacher, B. A.
    Ross-Degnan, D.
    Gurwitz, J. H.
    Pierre-Jacques, M.
    Safran, D. G.
    Adler, G. S.
    Soumerai, S. B.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 275 - 275
  • [32] Cost-Related Medication Nonadherence After Implementation of Medicare Part D, 2006-2007
    Madden, Jeanne M.
    Graves, Amy J.
    Ross-Degnan, Dennis
    Briesacher, Becky A.
    Soumerai, Stephen B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (16): : 1755 - 1756
  • [33] IS MEDICARE PART D PLAN BENEFIT DESIGN ASSOCIATED WITH COST-RELATED NONADHERENCE TO PRESCRIPTION DRUGS? AN ANALYSIS USING THE MEDICARE CAHPS DATA
    Wei, I. I.
    Howell, B. L.
    Frankenfield, D. L.
    Anderson, K. K.
    Sekscenski, E.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A171 - A172
  • [34] Prescription drug coverage satisfaction, cost-reducing behavior, and medication nonadherence among Medicare beneficiaries with type 2 diabetes
    He, Qing
    Silverman, Ciara L.
    Park, Chanhyun
    Tiu, Georgianne F.
    Ng, Boon Peng
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (06): : 696 - 705
  • [35] Cost-related skipping of medications and other treatments among medicare beneficiaries between 1998 and 2000 - Results of a national study
    Wilson, IB
    Rogers, WH
    Chang, H
    Safran, DG
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 (08) : 715 - 720
  • [36] Cost-related skipping of medications and other treatments among medicare beneficiaries between 1998 and 2000Results of a national study
    Ira B. Wilson
    William H. Rogers
    Hong Chang
    Dana Gelb Safran
    [J]. Journal of General Internal Medicine, 2005, 20 : 715 - 720
  • [37] The Relationship Between the Low-Income Subsidy and Cost-Related Nonadherence to Drug Therapies in Medicare Part D
    Wei, Iris I.
    Lloyd, Jennifer T.
    Shrank, William H.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (08) : 1315 - 1323
  • [38] THE ASSOCIATION BETWEEN PATIENT-PHYSICIAN COMMUNICATION AND COST-RELATED MEDICATION NON-ADHERENCE AMONG DIABETIC US MEDICARE BENEFICIARIES
    Zhang, J.
    Meltzer, D.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A173 - A173
  • [39] Impact of Cost-Related Medication Nonadherence on Economic Burdens, Productivity Loss, and Functional Abilities: Management of Cancer Survivors in Medicare
    Lu, Z. Kevin
    Xiong, Xiaomo
    Brown, Jacob
    Horras, Ashley
    Yuan, Jing
    Li, Minghui
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [40] Prescription Drug Insurance and Cost-Related Medication Nonadherence Among Lesbian, Gay, and Bisexual Individuals in Canada
    Gupta, Amit K.
    Salway, Travis
    [J]. LGBT HEALTH, 2022, 9 (06) : 426 - 435